SEC Comment Letter for DarioHealth Corp. (DRIO) (CIK 0001533998) (DRIO) — Oct 26, 2017
DarioHealth Corp. (DRIO) (CIK 0001533998)
Date: Oct. 26, 2017 · CIK: 0001533998 · Accession: 0000000000-17-037925
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-221025
Letter
Mail Stop 3030 October 26, 2017 Via E -mail Erez Raphael Chief Executive Officer DarioHealth Corp. 9 Halamish Street Caesarea Industrial Park 3088900, Israel
Re: DarioHealth Corp. Registration Statement on Form S-3 Filed October 19, 2017 File No. 333-221025
Dear Mr. Raphael :
This is to advise you that we have not reviewed and will not review your registration statement .
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Heather Percival at (202) 551 -3498 with any questions.
Sincerely,
/s/ Heather Percival for
Show Raw Text
Mail Stop 3030 October 26, 2017 Via E -mail Erez Raphael Chief Executive Officer DarioHealth Corp. 9 Halamish Street Caesarea Industrial Park 3088900, Israel Re: DarioHealth Corp. Registration Statement on Form S-3 Filed October 19, 2017 File No. 333-221025 Dear Mr. Raphael : This is to advise you that we have not reviewed and will not review your registration statement . Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Heather Percival at (202) 551 -3498 with any questions. Sincerely, /s/ Heather Percival for Amanda Ravitz Assistant Director Office of Electronics and Machinery cc: Robert V. Condon III, Esq. Sullivan & Worcester LLP